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Relationship Between Metabolic Syndrome and Familial History of
Hypertension/Stroke, Diabetes, and Cardiovascular Disease 
This research analyzes the prevalence of metabolic syndrome (MS) in Korea and
examines how the presence of a familial history of diseases related to MS, such as
hypertension/stroke, cardiovascular disease, and diabetes, affect the development of
MS in Koreans. The prevalence of MS and its components, as defined by the Nation-
al Cholesterol Education Program Adult Treatment Panel guidelines, were evalu-
ated in nationally representative samples of non-institutionalized civilian Koreans.
This analysis is based on the 2001 Korea National Health and Nutrition Examina-
tion Survey, which used a stratified multistage probability sampling design. The final
study included 5,742 adults who had completed the necessary health examinations
and met the diagnosis of MS. The prevalence of MS was 25.5% in men and 28.7%
in women. Odds ratio for MS among men with a familial history of hypertension/stroke
was higher than that among men who did not have this history. The OR for MS among
women with a familial history of hypertension/stroke or diabetes was higher than that
among women who had no familial history of these diseases. These results show
that familial history of hypertension/stroke and diabetes was significantly related to
the presence of MS in both young men and women.
Key Words : Metabolic Syndrome X; Causality; Predisposing Factor; Cardiovascular Diseases; Diabetes Mel-
litus, Type 2; Korea 
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INTRODUCTION
As a result of rapid socioeconomic growth and lifestyle
changes, cardiovascular disease has become increasingly preva-
lent and is now a leading cause of death in Korea. In order
to reduce the prevalence and mortality rate of cardiovascular
diseases, the various contributing risk factors must be ana-
lyzed and proactively controlled. Numerous studies conduct-
ed to identify the causal mechanisms of cardiovascular diseases
have suggested metabolic syndrome (MS) as a representative
biological mechanism. Ford (1) found that the mortality rates
for cardiovascular disease and coronary heart disease in a group
of subjects with MS were 1.37 (95% CI: 1.02-1.85) and 1.29
(95% CI: 0.92-1.82) times greater than in a group without
MS, respectively. These results support the role of MS as a
key predictor of cardiovascular disease.
Metabolic syndrome is associated with risk factors for car-
diovascular disease (2), and its symptoms include abdominal
obesity, low serum high-density lipoprotein (HDL) choles-
terol, elevated serum triglycerides (TG), hyperglycemia, and
high blood pressure (3). The WHO and the Third Report of
the National Cholesterol Education Program’s Adults Treat-
ment Panel (ATP III) recently emphasized the importance of
MS and proposed a working definition of this syndrome for
the first time (3, 4).
Research results provide a diverse set of risk factors that
contribute to MS. The prevalence and change in components
of MS are affected by psychosocial factors (5-8) such as indi-
vidual personality and stress as well as health behavior factors
such as smoking (9), alcohol use (9, 10), and physical exercise
(11-13). Moreover, data from recent studies show a correla-
tion between socioeconomic factors (14-20), such as educa-
tion level and household income, and individual components
of MS and cardiovascular diseases, demonstrating how MS
reflects social inequality. Other studies have shown that such
modifying factors combined with genetic predisposing fac-
tors contribute to MS. The effects of inherent hereditary fac-
tors cannot be modified through changes in behavior, mak-
ing genetics an important aspect of the prevalence of MS. Pre-
vious research into the relationship between genetic predis-
posing factors and MS suggests that individuals with a paren-
tal history of conditions such as hypertension/stroke or dia-
betes are more likely to develop MS or insulin resistance than
are people without a familial history of these diseases (21, 22).
This research analyzes the prevalence of MS in Korea and
demonstrates the relationship between familial history of relat-
ed diseases, such as hypertension/stroke, diabetes mellitus,
and cardiovascular disease, and the development of MS in
Koreans.MATERIALS AND METHODS
Study subjects
The Korea National Health and Nutrition Examination
Survey (KNHANES) has been conducted by the Korean
Ministry of Health and Welfare every 3 yr since 1998 and
includes non-institutionalized Korean civilians. The present
study is based on data from the 2001 KNHANES, which
uses a stratified multistage probability sampling design. The
final study subjects included 5,742 adults in their 20s who
completed the necessary health examinations for the diagno-
sis of MS.
Definition of metabolic syndrome
As detailed in the ATP III report, participants with three
or more of the following criteria were defined as having MS:
abdominal obesity (waist circumference >90 cm for men and
>80 cm for women; Asian Pacific Criteria), hypertriglyceri-
demia (≥150 mg/dL), low HDL cholesterol (<40 mg/dL for
men and <50 mg/dL for women), high blood pressure (≥
130/85 mmHg) and high fasting glucose (≥110 mg/dL).
We included participants who reported current use of anti-
hypertensive or diabetic medication (insulin or oral agents)
as participants with high blood pressure or diabetes, respec-
tively.
Definition of variables used in this study
The genetic predisposing factors considered in this research
were a history of hypertension/stroke, cardiovascular disease,
or diabetes in parents, siblings, paternal grandparents, or mater-
nal grandparents. If a relative had any one of these diseases,
the patient was deemed to have a familial history of that con-
dition. While the history of diabetes included patients of all
ages in the relatives, hypertension/stroke and cardiovascular
disease only included patients who are less than age 50 yr. The
demographic factors were sex, age, and menopausal status.
Menopausal status was determined at in-depth interview as
self-reported cessation of menstruation. Psychosocial factors
were measured based on stress levels and health concerns. The
level of stress was divided into three categories: high, moder-
ate, and low. The level of health concerns was divided into
three categories: high, moderate, and low. The socioeconomic
factors considered were education level and household income.
Education level was divided into four categories: less than 7
yr, 7-9 yr, 10-12 yr, and more than 12 yr. Monthly household
income was divided into three categories: less than USD1,000;
USD1,001 to 3,000; and more than USD3,001. The health
behavior factors examined were smoking, alcohol consump-
tion, exercise, and sleeping. With regard to smoking, the sub-
jects were categorized as smokers, ex-smokers, or never-smok-
ers. Ex-smokers were those who reported smoking at least 100
cigarettes during their lifetime but who did not currently
smoke cigarettes. The degree of alcohol consumption was
categorized as heavy, moderate, and never.
Health examination
Well-trained examiners conducted anthropometric mea-
surements on the individuals while they were wearing light
clothing or underwear and no shoes. Height was measured
to the nearest 0.1 cm using a portable stadiometer (850-2,060
mm; Seriter
�). Weight was measured in the upright position
to the nearest 0.1 kg using a calibrated balance beam scale
(Giant-150N; HANA
�). Waist circumference measurements
were taken to the nearest 0.1 cm at the end of a normal expi-
ration, measuring from the narrowest point between the lower
borders of the rib cage and the iliac crest. Systolic and dias-
tolic blood pressure levels were measured twice, using a mer-
cury sphygmomanometer (Baumanometer
�) at phases I and
V, respectively. Two readings each of systolic and diastolic
blood pressure were measured, and the average of each was
used for the data analysis. The first appearance of sound (phase
I Korotkoff sound) was used to define systolic blood pressure,
and the disappearance of sound (phase V Korotkoff sound)
was used to define diastolic blood pressure (23). The blood
pressure of each participant was measured in the sitting posi-
tion after a 5 min rest period. During the 30 min preceding
the measurements, the subjects were required to abstain from
smoking or consuming caffeine. Blood samples were collect-
ed from the antecubital vein after more than 10 hr of starva-
tion for the analysis of serum total cholesterol, triglycerides,
HDL cholesterol, and fasting blood glucose (FBS) (Hitachi-
747 autoanalyzer; Hitachi, Japan).
Statistics
The anthropometric characteristics and components of MS
were represented as means and 95% confidence intervals sep-
arated by sex. The sex- and age-specific prevalence rates of
MS were estimated. A multiple logistic regression analysis
was used for men and women to estimate the odds ratios of
MS based on familial history of the related diseases. We ana-
lyzed the data separately according to gender, using SPSS 11.0.
RESULTS
The anthropometric and sociodemographic characteristics
of the study subjects are summarized in Table 1. The sex- and
age-specific proportions of subjects with elements of MS appear
in Table 2. The most prevalent elements of MS among Kore-
an men and women were high blood pressure and low HDL
cholesterol, respectively. The sex-specific prevalence of each
component of MS increased with increasing age in both men
and women, and the difference between the sexes was statis-
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tically significant. A greater percentage of women (41.7%,
95% CI: 40.1-43.3%) than of men (24.0%; 95% CI: 22.4-
25.6%) had abdominal obesity, while a greater percentage
of men (43.8%, 95% CI: 41.9-45.7%) than women (26.5%,
95% CI: 25.1-27.9%) had high triglyceride levels. Low HDL
cholesterol was more prevalent in women (59.9%, 95% CI:
58.3-61.5%) than in men (37.4%, 95% CI: 35.6-39.2%).
The percentages of men and women with high blood pres-
sure were 46.2% (95% CI: 44.3-48.1%) and 31.5% (95%
CI: 30.0-33.1%), respectively, and the percentages of men
and women with high FBS were 18.8% (95% CI: 17.4-20.2
%) and 16.3% (95%CI: 15.1-17.5%), respectively.
The overall percentages of MS combined with these com-
ponents appear in Table 3. MS, as defined by the ATP III
guidelines, was present in 25.5% (95% CI: 23.8-27.2%) of
Characteristics
Measure-
ment
Men 
Number (%)
(n=2,456)
Women 
Number (%)
(n=3,286)
Table 1. Sociodemographic characteristics of study subjects
Sex
Age group
(yr)
Abdominal Obesity
% (95% Cl)
High triglycerides
% (95% Cl)
Low HDL cholesterol
% (95% Cl)
High blood pressure
% (95% Cl)
High glucose
% (95% Cl)
Men 20-39 18.8 (17.4-20.2)* 38.1 (36.3-39.9)* 34.4 (32.6-36.2)* 31.3 (29.5-33.1)* 10.9 (9.76-12.0)*
40-59 27.3 (25.7-28.9) 50.6 (48.7-52.5) 37.6 (35.8-39.4) 50.2 (48.3-52.1) 23.1 (21.6-24.6)
60+ 28.6 (26.9-30.3) 43.1 (41.2-45.0) 43.3 (41.5-45.1) 69.6 (67.8-71.4) 27.3 (25.7-28.9)
Total 24.0 (22.4-25.6)
� 43.8 (41.9-45.7)
� 37.4 (35.6-39.2)
� 46.2 (44.3-48.1)
� 18.8 (17.4-20.2)
�
Women 20-39 22.3 (21.0-23.6)* 16.3 (15.1-17.5)* 53.8 (52.2-55.4)* 8.2 (7.3-9.1)* 7.9 (7.0-8.8)*
40-59 48.4 (46.8-50.0) 28.6 (27.1-30.1) 59.7 (58.1-61.3) 32.8 (31.2-34.4) 16.8 (15.6-18.0)
60+ 68.1 (66.6-69.6) 43.6 (42.0-45.2) 72.6 (71.2-74.1) 72.7 (71.2-74.2) 31.8 (30.3-33.3)
Total 41.7 (40.1-43.3) 26.5 (25.1-27.9) 59.9 (58.3-61.5) 31.5 (30.0-33.1) 16.3 (15.1-17.5)
Table 2. The prevalence of each component of metabolic syndrome by sex and age group
Cl, confidence interval.
*p<0.01 (among age groups), 
�
p<0.01 (between men and women).
No. of 
metabo-
lic abno-
rmality
Men (n=2,456)
Metabolic 
syndrome
Prevalence
% (95%CI)
Proportion
% (95%CI)
Cumulative
% 
0 No 21.2 (19.6-22.8) 21.2
1 27.3 (25.5-29.0) 48.5
2 26.0 (24.3-27.8) 74.5
3 Yes 25.5 (23.8-27.2) 17.0 (15.5-18.5) 91.5
4 6.8 (5.8-7.8) 98.3
5 1.7 (1.2-2.2) 100.0
No. of 
metabo-
lic abno-
rmality
Women (n=3,286)
Metabolic 
syndrome
Prevalence
% (95%CI)
Proportion
% (95%CI)
Cumulative
% 
0 No 20.6 (19.2-22.0) 20.6
1 28.4 (26.9-30.0) 49.0 
2 22.3 (20.9-23.7) 71.3 
3 Yes 28.7 (27.2-30.2) 15.8 (14.6-17.1) 87.1
4 9.6 (8.6-10.6) 96.7
5 3.3 (2.7-3.9) 100.0
Table 3. The Distribution of metabolic abnormality and the preva-
lence of metabolic syndrome*
Cl, confidence interval.
*No response or unknown data were excluded.
Genetic predisposing factors
Familial history of  No 2,096 (85.3) 2,805 (85.4)
hypertension/stroke Yes 360 (14.7) 481 (14.6)
Familial history of cardio- No 2,380 (96.9) 3,176 (96.7)
vascular disease Yes 76 (3.1) 110 (3.3)
Familial history of diabetes No 2,194 (89.3) 2,911 (88.6)
Yes 262 (10.7) 375 (11.4)
Demographic factors
Age (yr) 20-39 1,028 (41.9) 1,382 (42.1)
40-59 94 9 (38.6) 1,194 (36.3)
60+ 479 (19.5) 710 (21.6)
Menopausal state
Postmenopausal 1,936 (63.1)
Premenopausal 1,132 (36.9)
Socioeconomic factors
Education level (yr) <7 385 (15.7) 966 (29.4)
7-9 304 (12.4) 425 (12.9)
10-12 895 (36.5) 1,167 (35.6)
>12 870 (35.5) 724 (22.1)
Household income  ≤1,000 664 (28.7) 965 (31.2)
(USD/mon) 1,001-3,000 1,446 (62.4) 1,840 (59.5)
≥3,001 206 (8.9) 289 (9.3)
Psychosocial factors
Stress High 761 (34.0) 1,048 (34.1)
Moderate 1,072 (47.8) 1,475 (48.0)
Low 408 (18.2) 547 (17.8)
Concern for health High 419 (18.7) 757 (24.6)
Moderate 1,245 (55.6) 1,652 (53.8)
Low 575 (25.7) 662 (21.6)
Health behavioral factors
Alcohol consumption Heavy 618 (27.6) 116 (3.8)
Moderate 882 (39.3) 714 (23.2)
Never 743 (33.1) 2,243 (73.0)
Smoking Current 1,326 (59.1) 149 (4.8)
Past 444 (19.8) 40 (1.3)
Never 472 (21.1) 2,884 (93.8)
Exercises Yes 730 (32.6) 752 (22.9)
No 1,510 (67.4) 2,319 (70.6)
Sleeping Enough 1,459 (65.2) 1,940 (63.3)
Not enough 778 (34.8) 1,126 (36.7)704 K.W. Paek, K.H. Chun, K.W. Lee
the men and in 28.7% (95% CI: 27.2-30.2%) of the women.
Table 4 and 5 show the adjusted OR for the associations bet-
ween a familial history of related diseases and the risk of MS
in men and women. Odds ratio (OR) for MS in men with a
familial history of hypertension (or stroke) (OR: 1.41, 95%
CI: 1.08-1.84%) was higher than that in men without a his-
tory. ORs for MS in women with a familial history of hyper-
tension/stroke (OR: 1.74, 95% CI: 1.35- 2.24%) or cardio-
vascular disease (OR: 1.56, 95% CI: 0.96-2.55%) or diabetes
(OR: 1.71, 95% CI: 1.28-2.27%) were higher compared with
Variable
Model 1
OR (95% CI) p-value
Model 2
OR (95% CI) p-value
Model 3
OR (95% CI) p-value
Table 4. Variables affecting to metabolic syndrome in men
CVD, cardiovascular disease; OR, odds ratio; Cl, confidence interval.
Genetic predisposing factors
Familial history of hypertension/stroke
No 1.0 (referent)
Yes 1.41 (1.08-1.84) <0.05
Familial history of cardiovascullar disease
No 1.0 (referent)
Yes 1.18 (0.68-2.05) NS
Familial history of diabetes
No  1.0 (referent)
Yes 1.35 (0.99-1.84) NS
Demographic factors
Age (yr)
20-39 1.0 (referent) 1.0 (referent) 1.0 (referent)
40-59 1.97 (1.54-2.53) <0.001 1.98 (1.55-2.54) <0.001 2.01 (1.57-2.57) <0.001
≥60 2.71 (1.94-3.80) <0.001 2.69 (1.92-3.77) <0.001 2.74 (1.95-3.84) <0.001
Socioeconomic factors
Education level (yr)
<7 1.0 (referent) 1.0 (referent) 1.0 (referent)
7-9 1.03 (0.72-1.48) NS 1.03 (0.71-1.47) NS 1.02 (0.71-1.46) NS
10-12 1.03 (0.75-1.42) NS 1.04 (0.76-1.44) NS 1.03 (0.75-1.42) NS
>12 1.00 (0.71-1.41) NS 1.01 (0.71-1.43) NS 0.99 (0.77-1.40) NS
Household income (USD/mon)
≤1,000 1.0 (referent) 1.0 (referent) 1.0 (referent)
1,001-3,000 1.08 (0.86-1.37) NS 1.08 (0.85-1.36) NS 1.07 (0.84-1.35) NS
≥3,001 0.86 (0.57-1.30) NS 0.85 (0.56-1.29) NS 0.85 (0.56-1.29) NS
Psychosocial factors
Stress
High 1.01 (0.75-1.36) NS 1.01 (0.76-1.36) NS 1.01 (0.75-1.36) NS
Moderate 0.75 (0.57-0.99) <0.05 0.76 (0.58-1.00) <0.05 0.76 (0.58-1.01) <0.05
Low 1.0 (referent) 1.0 (referent) 1.0 (referent)
Concern for health
High 1.07 (0.79-1.44) NS 1.08 (0.80-1.46) NS 1.07 (0.79-1.45) NS
Moderate 1.13 (0.89-1.44) NS 1.13 (0.89-1.45) NS 1.12 (0.88-1.43) NS
Low 1.0 (referent) 1.0 (referent) 1.0 (referent)
Health behavioral factors
Drinking
Heavy 1.05 (0.82-1.36) NS 1.06 (0.82-1.37) NS 1.07 (0.83-1.38) NS
Moderate 1.00 (0.79-1.28) NS 1.01 (0.80-1.29) NS 1.02 (0.80-1.30) NS
Never 1.0 (referent) 1.0 (referent) 1.0 (referent)
Smoking
Current 0.92 (0.71-1.19) NS 0.91 (0.70-1.18) NS 0.91 (0.70-1.17) NS
Past 1.10 (0.81-1.49) NS 1.08 (0.80-1.46) NS 1.09 (0.80-1.47) NS
Never 1.0 (referent) 1.0 (referent) 1.0 (referent)
Exercises
Yes 1.02 (0.82-1.27) NS 1.03 (1.01-1.58) NS 1.03 (0.83-1.27) NS
No 1.0 (referent) 1.0 (referent) 1.0 (referent)
Sleeping
Enough 1.27 (1.01-1.59) <0.05 1.26 (1.06-1.56) <0.05 1.26 (1.01-1.58) <0.05
Not enough 1.0 (referent) 1.0 (referent) 1.0 (referent)those in women with no familial history of these conditions.
The association between MS and age increased gradually in
both men and women, and a significantly higher OR (Model
1: 2.08, Model 2: 2.10, Model 3: 2.12) was observed in post-
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Variable
Model 1
OR (95% CI) p-value
Model 2
OR (95% CI) p-value
Model 3
OR (95% CI) p-value
Table 5. Variables affecting to metabolic syndrome in women
CVD, cardiovascular disease; OR, odds ratio; Cl, confidence interval.
Genetic predisposing factors
Familial history of hypertension/stroke
No 1.0 (referent)
Yes 1.74 (1.35-2.24) <0.001
Familial history of cardiovascular disease
No 1.0 (referent)
Yes 1.56 (0.96-2.55) <0.05
Familial history of diabetes
No  1.0 (referent)
Yes 1.71 (1.28-2.27) <0.001
Demographic factors
Age (yr)
20-39 1.0 (referent) 1.0 (referent) 1.0 (referent)
40-59 1.64 (1.24-2.18) <0.01 1.67 (1.26-2.22) <0.001 1.68 (1.26-2.22) <0.001
≥60 3.24 (2.19-4.80) <0.001 3.33 (2.25-4.92) <0.001 3.36 (2.27-5.00) <0.001
Menstruation
Menopausal 1.0 (referent) 1.0 (referent) 1.0 (referent)
Postmenopausal 2.08 (1.58-2.74) <0.001 2.10 (1.59-2.76) <0.001 2.12 (1.61-2.78) <0.001
Socioeconomic factors
Education level (yr)
<7 1.0 (referent) 1.0 (referent) 1.0 (referent)
7-9 1.20 (0.90-1.60) NS 1.27 (0.96-1.69) NS 1.27 (0.95-1.68) NS
10-12 0.55 (0.41-0.73) <0.001 0.59 (0.44-0.78) <0.001 0.58 (0.44-0.77) <0.001
>12 0.30 (0.20-0.44) <0.001 0.32 (0.22-0.47) <0.001 0.31 (0.21-0.45) <0.001
Household income (USD/mon)
≤1,000 1.0 (referent) 1.0 (referent) 1.0 (referent)
1,001-3,000 1.07 (0.87-1.31) NS 1.06 (0.86-1.31) NS 1.07 (0.87-1.32) NS
≥3,001 1.01 (0.69-1.47) NS 1.00 (0.68-1.46) NS 1.01 (0.69-1.48) NS
Psychosocial factors
Stress
High 0.83 (0.63-1.07) NS 0.84 (0.65-1.09) NS 0.85 (0.66-1.11) NS
Moderate 0.78 (0.61-1.00) <0.05 0.79 (0.62-1.01) <0.05 0.79 (0.62-1.01) <0.05
Low 1.0 (referent) 1.0 (referent) 1.0 (referent)
Concern for health
High 1.72 (1.30-2.27) <0.001 1.72 (1.30-2.27) <0.001 1.73 (1.31-2.28) <0.001
Moderate 1.22 (0.95-1.57) NS 1.23 (0.96-1.57) NS 1.23 (0.96-1.58) NS
Low 1.0 (referent) 1.0 (referent) 1.0 (referent)
Health behavioral factors
Drinking
Heavy 1.19 (0.74-1.93) NS 1.22 (0.75-1.96) NS 1.23 (0.77-1.99) NS
Moderate 1.09 (0.86-1.39) NS 1.10 (0.87-1.40) NS 1.08 (0.85-1.37) NS
Never 1.0 (referent) 1.0 (referent) 1.0 (referent)
Smoking
Current 0.91 (0.61-1.34) NS 0.91 (0.62-1.35) NS 0.94 (0.64-1.39) NS
Past 0.78 (0.35-1.74) NS 0.75 (0.34-1.67) NS 0.75 (0.34-1.65) NS
Never 1.0 (referent) 1.0 (referent) 1.0 (referent)
Exercises
Yes 1.02 (0.76-1.18) NS 0.96 (0.75-1.16) NS 0.93 (0.75-1.16) NS
No 1.0 (referent) 1.0 (referent) 1.0 (referent)
Sleeping
Enough 1.28 (1.06-1.56) <0.05 1.28 (1.06-1.56) <0.05 1.30 (1.07-1.58) <0.01
Not enough 1.0 (referent) 1.0 (referent) 1.0 (referent)706 K.W. Paek, K.H. Chun, K.W. Lee
menopausal women. Education as a socioeconomic risk fac-
tor was statistically significant for women; a higher level of
education was significantly associated with a lower prevalence
of MS. Stress as a psychosocial factor was statistically signif-
icant in both men and women. Overall, patients who were
subjected to moderate amounts of stress had statistically lower
OR for MS than did those subjected to severe or no stress.
Concern for health as a psychosocial factor was statistically
significant only in women. The patient group that expressed
constant concern for their health had significantly higher
prevalence of MS than did the other groups. Of the health
behavior factors, only the level of sleep had statistical signif-
icance for both men and women. The participants who report-
ed getting enough sleep had higher prevalence of MS compared
with those who reported a chronic lack of sleep.
DISCUSSION 
Among Korean adults in this study, the overall prevalence of
MS, as defined by the ATP III, was 25.5% (95% CI: 23.8-
27.2%) for men and 28.7% (95% CI: 27.2-30.2%) for women.
These figures show a notable increase from the research results
from Park et al. (14.2% for men, 17.7% for women) (24) and
Kim et al. (22.1% for men, 27.8% for women) (25) based
on the 1998 KNHANES data. However, it should be noted
that Park’s research applied different abdominal obesity cri-
teria (>102 cm for men and >88 cm for women) than those
used in this research. Yoon et al. (26) used the same abdom-
inal obesity criteria as in the present study and reported MS
prevalence rates of 20.8% and 26.9% for men and women,
respectively. In this research, only 20.6% (95% CI: 19.2-
22.0%) of females and 21.2% (95% CI: 19.6-22.8%) of males
in the population had no components of MS. More than 4/5
of the adult population in their 20s had one or more compo-
nents of MS.
Among the genetic predisposing factors that affect the pre-
valence of MS, familial histories of hypertension/stroke and
of diabetes were significant for both men and women. Liese
et al. (22) reported that children with either diabetes or hyper-
tension in their familial histories had a higher incidence rate
of MS than did children without such history and that chil-
dren with familial histories on both parents’ sides had an OR
of 4.7 (95% CI: 1.5-14.7%) for these conditions. Williams
et al. (27) studied metabolic abnormalities in high school
students with familial histories of hypertension and coronary
heart disease and reported a higher risk for the onset of MS
elements, such as abdominal obesity, hypertension, and dys-
lipidemia, in this population.
The present study extends the scope of genetic influence
on MS by including parents, grandparents, and siblings in
the familial history. The results indicate that a familial his-
tory of hypertension/stroke is statistically significance for an
increased risk of MS in both men and women. Additionally,
because MS serves as a risk factor for chronic diseases such as
cardiovascular diseases and diabetes, we can predict that a fami-
lial history of hypertension/stroke affects the onset of these
diseases. For women, a familial history of hypertension/stroke
yielded an OR of 1.74 (95% CI: 1.35-2.24) for the onset of
MS, a familial history of cardiovascular disease yielded an OR
of 1.56 (95% CI: 0.96-2.55) and a familial history of diabetes
yielded an OR of 1.71 (95% CI: 1.28-2.27). For men, only
a familial history of hypertension/stroke was statistically sig-
nificant and yielded an OR of 1.41 (95% CI: 1.08-1.84) for
the onset of MS. These ratios indicate that familial histories of
hypertension/stroke and diabetes have a greater effect on women
than on men in terms of the onset of chronic diseases.
As a demographic factor, age was statistically significant
for both men and women, and menopause was a major factor
among women. We found a significantly higher OR (Model
1: 2.08, Model 2: 2.10, Model 3: 2.12) for the onset of MS
among menopausal women, while Park et al. (28) reported
an OR of 1.6 (95% CI: 1.1-2.3), indicating a higher preva-
lence among menopausal women.
The prevalence of MS was significantly higher among wo-
men with lower levels of education. Winkleby et al. (29) de-
fined the three factors of the socioeconomic metric as educa-
tion, income, and occupation and used them to analyze the
changes in health risk factors. The risk for cardiovascular dis-
ease according to socioeconomic levels suggested that people
of lower socioeconomic status, including lower education level,
had statistically significant higher the risk of prevalence of
risk factors (HDL cholesterol, and total cholesterol values).
The psychosocial factor of stress was significant for both men
and women. Subjects who indicated moderate stress levels
had the lowest prevalence of MS, suggesting that moderate
stress may have a positive effect of on health.
Among the health behavior factors, sleep and the preva-
lence of MS were significantly related. Previous research on
alcohol consumption, smoking, and exercise found that sub-
jects who used to be heavy smokers but no longer smoked
had low HDL cholesterol levels and that subjects who cur-
rently smoked exhibited metabolic irregularities caused by
acute insulin resistance (30). Long-term smoking, regardless
of age, was associated with a statistically significant increase
in the coronary heart disease factors of total cholesterol and
TG. Although alcohol consumption was found to lower insulin
levels (31) and increase insulin sensitivity (32-34) and had a
significant inverse relation with OR low HDL cholesterol
(26, 34, 35), previous research showed that light to moder-
ate alcohol consumption by severely obese subjects decreased
the prevalence of type 2 diabetes and that moderate alcohol
consumption by diabetic patients significantly lowered the
likelihood of coronary heart disease (24, 36). Additionally,
regular exercise was reported to lower total cholesterol, LDL
cholesterol, and triglycerides, while increasing HDL choles-
terol, thereby improving the overall lipid distribution (24,
37). Exercise can also affect blood sugar levels by delayingMetabolic Syndrome and Familial History 707
or suppressing the progression of glucose intolerance in dia-
betes and can block the rise in blood sugar levels by reducing
insulin resistance in diabetes (38). However, the present study
found that health behavior factors (smoking, alcohol consump-
tion, and exercise) were not statistically related to MS. This
indicates that the relationship between such risk factors for
cardiovascular disease and diabetes and MS as an initial stage
of chronic disease has yet to be established.
The research presented in this paper analyzed demographic,
socioeconomic, psychosocial, and health behavioral risk fac-
tors for MS focusing on the genetic predisposing factors. The
results show that the MS is closely related to the age and the
familial history of hypertension/stroke or diabetes, but is not
significantly related to the health behaviors that are known
major risk factors for the chronic diseases. Familial history
factors could represent the genetic as well as the environmen-
tal factors of patients. This may limit identifying the isolat-
ed relationship between genetic factors and MS. 
While both MS and health behaviors are established as
major risk factors for cardiovascular diseases and diabetes,
the results show that MS is not significantly related to health
behaviors. However, even though the risk factors for cardio-
vascular diseases and diabetes, the presence of MS, and the
practice of certain health behaviors are independent of each
other, the results of this study suggest that the practice of cer-
tain health behaviors can enhance the significance of the rela-
tionship between MS and chronic diseases such as cardiovas-
cular disease and diabetes. Therefore, MS may be used as a
primary predictor for the onset of chronic disease later in life.
Unfortunately, this research did not include eating behavior,
which is one of the many factors to consider when using MS
as a research parameter.
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